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DObjective:Owing to the mismatch between cardiopulomary bypass priming volume and infants’ blood volume,
pediatric cardiac surgery is often associated with transfusion of homologous blood, which may increase the risk
of perioperative complications. Here we report the impact of a very low volume (95-110 mL) cardiopulmonary
bypass circuit during arterial switch operations in neonates with transposition of the great arteries on blood re-
quirements, tissue oxygenation, and patient outcome.
Methods: Twenty-three consecutively treated neonates aged 2 to 17 days were treated with the blood-sparing
approach. Asanguineous priming was used in all cases and packed red blood cells were added when hemoglobin
concentration decreased below 7 g/dL. Cerebral and lower body tissue oxygenation was monitored by near-
infrared spectroscopy. Intraoperative and postoperative transfusion, duration of ventilation and intensive care
unit stay, wound infection, and 30-day mortality were assessed for patient outcome.
Results: Intraoperative blood transfusion was necessary in 6 of 23 neonates. An additional 11 neonates received
postoperative blood transfusions on the intensive care unit, leaving 6 infants who received no blood at all. Pre-
operative hemoglobin concentration was the only predictor for intraoperative transfusion requirement (11.6 
0.9 and 13.3  0.4 g/dL in infants with and without intraoperative transfusion, respectively). Despite marked
differences in hemoglobin concentrations between infants with and without transfusion, regional tissue oxygen-
ation increased in both groups during cardiopulmonary bypass and returned to baseline at the end of surgery.
In-hospital patient outcome was similar in both groups.
Conclusions: Transfusion-free complex cardiac surgery can be achieved even in neonates without jeopardizing
tissue oxygenation or patient safety. (J Thorac Cardiovasc Surg 2011;142:875-81)C
HDuring the past decades, improvements in cardiopulmonary
bypass (CPB), surgical techniques, and intensive care have
facilitated complex surgical procedures for the correction of
congenital heart disease in even the smallest neonates. Al-
though perioperative mortality is acceptably low in this spe-
cial population,1,2 complications may be quite frequent.
These include low output syndrome, arrhythmias, wound
infection, inflammatory responses including sepsis, and,
for years after surgery, neurologic abnormalities such as
hypotonia, developmental delay, or attention deficit. The
risk of complications may be increased by transfusion of
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The Journal of Thoracic and Cahemoglobin concentration and hematocrit value within
a range that guarantees sufficient oxygen transport
capacity. Hemoglobin decreases owing to blood loss
during surgery but mainly owing to the size of the CPB
circuit’s priming volume versus the infant’s blood
volume. Intraoperative blood loss can be minimized by
optimizing the surgical technique to reduce or even avoid
hemodilution. The effect of blood loss on hemoglobin
may be partially equalized by using cell salvage
techniques and retransfusing the red blood cells. Pivotal
for limiting hemodilution is reduction of the priming
volume of the CPB circuit. That may reduce not only
anemia but also dilutional thrombocytopenia and dilution
of plasmatic coagulation factors.9
In a joint effort of surgeons, perfusionists, and anesthesi-
ologists, the CPB circuit used in pediatric cardiac surgery
was redesigned to minimize the priming volume to 95 to
110 mL,10 and standard procedures were adapted with the
goal of minimizing intraoperative hemodilution. The ex-
pected benefits of this approach are reduced need for trans-
fusion of homologous blood products and better
preservation of the coagulatory system. To recognize and
avoid regional ischemia, we used near-infrared spectros-
copy (NIRS) for monitoring of brain and lower body tissuerdiovascular Surgery c Volume 142, Number 4 875
Abbreviations and Acronyms
CPB ¼ cardiopulmonary bypass
ICU ¼ intensive care unit
NIRS ¼ near-infrared spectroscopy
rSO2 ¼ regional tissue oxygenation
TGA ¼ transposition of the great arteries
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Doxygenation.11 Here we report our experience with this ap-
proach, its limitations, and its effects on tissue oxygenation
and early patient outcome for a cohort of 23 neonates who
were referred for surgical treatment of transposition of the
great arteries (TGA) by the arterial switch operation.METHODS
Patients
Between April 2007 and December 2009, 23 neonates were treated by
the arterial switch operation for TGAwith application of the ‘‘blood-spar-
ing’’ approach. This included the use of the low priming volume CPB,
avoidance of all additional hemodilution by minimizing blood sampling
and by not using ultrafiltration, meticulous surgical technique to reduce
bleeding, a transfusion trigger of hemoglobin concentration less than 7 g/
dL, and NIRS to ensure maintenance of cerebral and peripheral oxygena-
tion. Ages ranged from 4 to 17 days, body weight was between 1.7 and
4.2 kg, and body size between 43 and 55 cm. All parents gave informed
written consent for the surgical, anesthesiologic, and monitoring proce-
dures. The retrospective data analysis was approved by the institutional re-
view board.
CPB and Surgery
A CPB circuit was redesigned for use in neonates as described previ-
ously.10,12,13 A St€ockert S3 mast mounted console (St€ockert Instrumente
GmbH, Munich, Germany) was modified by shortening as much as
possible all tubing connections. All tubings were 3/16-inch internal
diameter except the arterial pump boot (1/4-inch) and suction lines (1/8-
inch). Low prime oxygenator (KIDS D100, Sorin, Mirandola, Italy) and
arterial line filter (D130, Sorin) were used. Both for increase of venous
return and for suction lines, roller pump suction heads were used. This
modified system has a total priming volume of 110 mL, which was
further reduced to 95 mL for neonates of less than 3-kg body weight by
using 3/16-inch internal diameter tubing for the arterial pump boot.
Asanguineous priming of the CPBwas used in all patients. Immediately
after mixing of the priming volume with the patients’ blood, hemoglobin
concentrations were assessed and packed red blood cells were added
when the transfusion trigger of hemoglobin less than 7 g/dL was reached.
Antifibrinolysis was achieved by infusing 10 mg $ kg1 $ h1 of tranexamic
acid. During CPB, hypothermia to 26C to 28C was induced.
TGA was corrected by arterial switch. In addition, a ventricular septal
defect was closed in 2 cases, the arterial duct ligated in 2 cases, and a hypo-
plastic aortic arch was reconstructed in 1 case.
Monitoring
Heart rate, arterial and central venous pressure, and temperatures were
continuously monitored and data were read out at the times of blood gas
analyses. Arterial blood gases were drawn and analyzed (Rapidlab 865;
Siemens Healthcare Diagnostics, Inc, Deerfield, Ill) before surgery (preop),
after the onset of CPB (CPB start), at 15-minute intervals during CPB (CPB
mid), briefly before termination of CPB (CPB end), and during chest clo-876 The Journal of Thoracic and Cardiovascular Surgsure (post-CPB). Central venous blood was analyzed during chest opening
(pre-CPB) and after surgery (postop).
NIRS
A near-infrared spectrometer (NIRO-200; Hamamatsu Photonics KK,
Hamamatsu City, Japan) equipped with 2 independent emitter–sensor
pairs, each with a spatial separation of 4 cm, was used. One pair of optodes
was placed noninvasively on the patient’s forehead for monitoring of brain
oxygenation, and the second onewas placed on the right calf for monitoring
of lower body tissue oxygenation. Light was generated by 3 pulsed laser
diodes at wavelengths of 775, 810, and 850 nm and emitted into the tissue
through the source optode. Backscattered light from the tissue was col-
lected by the detection probe equipped with a dual-segmented photodiode
chip. With the spatially resolved spectroscopy method, regional tissue ox-
ygenation (rSO2) was calculated.
14,15
Statistics
Patient characteristics and outcome data were compared between
groups by the t test for normally distributed data and by the Mann-
Whitney test for intensive care unit (ICU) stay and ventilation. Incidence
of postoperative transfusion, wound infection, and mortality was analyzed
by Fisher’s exact test. The time course of perioperative parameters was an-
alyzed by repeated measures analysis of variance followed by Holm-Sidak
post hoc analyses.RESULTS
Initial priming without blood was attempted in all 23
cases. In 6 cases, between 50 and 125 mL (mean, 97  11
mL) of packed red blood cells were transfused during the
procedure because the transfusion trigger of a hemoglobin
level less than 7.0 g/dL was met. In 3 cases, 50 to 70 mL
of fresh frozen plasmawas additionally transfused. In 17 ne-
onates surgery could be completed without transfusion of
any homologous blood products. Thus, 1 group of neonates
(with blood, n¼ 6) received intraoperative blood transfusion
whereas the other group (without blood, n¼ 17) did not. The
2 groups did not differ in age, size, or body weight (Table 1).
All 6 neonates (100%) from the transfused group and 11 ne-
onates (65%) from the group without blood received trans-
fusion of blood products on the pediatric ICU (for details see
Table 2) resulting in 6 patients who received intraoperative
and postoperative transfusion, 11 patients without intraoper-
ative but with postoperative transfusion, and 6 patients who
did not receive any homologous blood products. Patient out-
come as assessed by duration of ventilation, ICU stay, the
rate of wound infection,mortality, or inflammatory response
(peak C-reactive protein) was similar among groups
(Tables 1 and 2).
Preoperative hemoglobin was higher in the group without
blood (13.3  0.4 g/dL) than in the neonates who received
blood transfusion (11.6  0.9 g/dL) and decreased to, re-
spectively, 9.1  0.3 and 6.8  0.4 g/dL with the onset of
CPB (Figure 1). In patients with blood, hemoglobin levels
increased markedly during CPB and reached the preopera-
tive level after retransfusion of the CPB priming volume to-
ward the end of the operation. In contrast, in patients
without blood, hemoglobin remained essentially unchangedery c October 2011
TABLE 1. Patient characteristics and in-hospital outcome
With blood Without blood P value
N 6 17
Age (d) 8.7  1.2 9.1  4.4 .807
Size (cm) 50  1 51  3 .540
Body weight (kg) 3.1  0.4 3.4  0.6 .353
CPB time (min) 148  58 120  21 .096
Aortic clamp time (min) 93  24 80  14 .123
Postop transfusion 6 (100%) 11 (65%) .144
ICU stay (min)
Range 3-21 1-11 .401
Median (25/75) percentiles 5.5 (3.5/6.0) 4.0 (2.0/7.0)
Ventilation (h)
Range 26-515 22-167 .529
Median (25/75) percentiles 56 (40/100) 48 (29/102)
Wound infection 1 (17%) 4 (24%) 1.00
Mortality (30 d) 1 (17%) 0 .261
CRP (mg/100 mL) 8.6  4.9 6.5  4.7 .310
Data are means  standard deviation or median and 25 and 75 percentiles as appro-
priate. CPB, Cardiopulmonary bypass; ICU, intensive care unit; CRP, C-reactive pro-
tein. The group of infants without intraoperative blood transfusion was additionally
divided into neonates who received postoperative transfusions (n ¼ 11) and those
who did not (n ¼ 6). There was no major difference in the outcome parameters be-
tween these subgroups (data not shown). P values were assessed by t test for normally
distributed data, by Mann-Whitney rank sum test for intensive care unit stay and ven-
tilation, and by Fisher’s exact test for incidence of postoperative transfusion, wound
infection, and 30-day mortality.
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Dduring CPB and increased only slightly after termination of
CPB and retransfusion of the priming volume. Thus, at the
end of the operation, hemoglobin was significantly higher in
patients with blood (11 0.5 g/dL) than without blood (9.8
 0.4 g/dL). CPB flow and oxygen delivery were similar in









N 6 11 6
Postop PRBCs 4 11 0
Postop FFP 5 2 0
Postop platelets 1 0 0
ICU stay (d)
Range 3-21 2-11 1-9 .575
Median (25/75)
percentiles
5.5 (3.5/6.0) 5.0(2.5/7.0) 4.0 (2.5/4.8)
Ventilation (h)
Range 26-515 22-167 22-140 .772
Median (25/75)
percentiles
56 (40/100) 48 (29/110) 49 (31/69)
Wound infection 1 (17%) 2 (18%) 2 (33%) .724
Mortality (30 d) 1 (17%) 0 0 .227
CRP (mg/100 mL) 8.6  4.9 6.7  5.0 6.2  4.3 .574
Transfusion requirements (FFP, fresh frozen plasma; PRBCs, packed red blood cells)
are given as numbers of patients who received any of these products for the group with
intraoperative transfusion (with blood), the group without intraoperative but with
postoperative transfusion (without blood [postop blood]), and the group without
any transfusion of homologous blood products (without blood). Outcome data that
had already been given in Table 1 are specified for these groups. ICU, Intensive
care unit; CRP, C-reactive protein.
The Journal of Thoracic and CaBlood gas and acid–base data are listed in Table 3. There
were no preoperative differences between groups. Onset of
CPB terminated the TGA-induced cyanosis in both groups.
Arterial oxygen content decreased in both groups with the
onset of CPB and remained decreased in neonates in the
without blood group until the end of the procedure. Central
venous oxygen content at the end of the procedure was de-
creased only in the without blood group. The pH was kept
unchanged, but base excess decreased more in the group
with blood. In both groups, plasma lactate concentration
significantly increased during the procedure, but markedly
more in patients with blood than in those without blood. Ar-
terial and central venous pressures and body temperature
were similar in both groups.
Preoperative cerebral tissue oxygenation was similar in
both groups and was significantly increased in patients in
the group with blood during CPB (Figure 2). In patients
without blood there was also a trend for increased cerebral
rSO2, which became statistically significant at the end of
CPB. After CPB, cerebral rSO2 returned to preoperative
values in both groups. Lower body rSO2 as measured on
the calf was also similar before surgery, increased in both
groups during CPB, but remained elevated until the end
of surgery only in the group of neonates treated without
blood (Figure 3).
DISCUSSION
The major message of this study is that minimizing the
CPB priming volume during cardiac surgery for correction
of complex congenital cardiac defects such as TGA reduced
the need for blood transfusion even in neonates without
jeopardizing tissue oxygenation or patient safety.
Successful attempts to minimize hemodilution and avoid
transfusion of homologous blood products in pediatric car-
diac surgery have been reported previously. Ootaki and asso-
ciates16 established a criterion-driven transfusion protocol,
with hematocrit less than 15% during CPB and less than
20% after surgery or a mixed venous oxygen saturation be-
low 50% as transfusion triggers. Fifty-three (71%) of 75 in-
fants could be operated on without blood transfusion.
However, the infants in this study had an average age of
3.2 and 7.9 years and a mean body weight of 11.2 and 24.6
kg in the groups with and without blood transfusion, respec-
tively. Ando and colleagues4 introduced a miniaturized CPB
circuit with priming volumes of 160 and 130mL for children
with body weights above and below 4.5 kg, respectively.
They report results for 158 consecutive patients who were
operated on for repair of ventricular septal defect. The
CPB circuit was primed with blood only if hematocrit value
was expected to decrease below15%. Thus, 122 infantswere
operated onwithout blood transfusion and only 6 of these re-
ceived blood transfusion postoperatively. The mean age of
the infants without blood was 3.8 months and the mean
body weight was 4.3 kg. Kotani and coworkers17 reportedrdiovascular Surgery c Volume 142, Number 4 877
FIGURE 1. The course of blood hemoglobin (Hb) concentrations during
cardiac surgery is given for neonates without intraoperative blood transfu-
sion (w/o blood) and with blood transfusion (with blood). Means  SEM;
*P<.05 versus pre Op; #P<.05 w/o blood versus with blood. CPB, Car-
diopulmonary bypass.
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Dtheir experiencewith a low priming volumeCPB circuit with
300 mL or 550 mL for flow rates below and above 1500mL/
min, respectively. Of 536 children with body weight greater
than5 kg, 264 (49%)were operated on for various congenital
cardiac defects without receiving homologous blood prod-
ucts. Transfusion trigger was a hematocrit value less than
20% for patients with biventricular repair and less than
25% for patients with single ventricle palliation. Mean age
and bodyweight in the nontransfusion groupwere 37months
and 12.2 kg, respectively. Miyaji and colleagues18 presented
a miniaturized CPB circuit with a priming volume of 140
mL, which allowed for blood-free priming for children
with a body weight between 4 and 7 kg. Hematocrit value
during CPB less than 20%, central venous oxygen saturation
less than 70%, brain oxygenation as measured by NIRS less
than 50%, and lactate levels greater than 4 mmol/L were the
triggers for blood transfusion. Forty-five (64%) of 70 infants
were operated on without blood transfusion. Mean body
weight of the nontransfused group was 5.6 kg.
The present study differs from these previous reports by
including only neonates with body weights between 2.7 and
4.2 kg undergoing the complex surgical procedure of switch
operation for TGA. Yet surgery could be completed without
blood transfusion in 74% of cases and in 26% blood trans-
fusion could be completely avoided. However, also neo-
nates receiving blood transfusion in the ICU may profit
from the blood-free completion of CPB because reduction
of priming volume has been shown to ameliorate the inflam-
matory response to pediatric cardiac surgery independently
from blood transfusion.19,20 In addition, the minimized
CPB circuits also reduce dilution of platelets and
plasmatic coagulation factors that may result in better
preservation of the hemostatic system.9878 The Journal of Thoracic and Cardiovascular SurgPivotal for these results is the CPB circuit presented here,
which is unique as compared with the circuits discussed
above by its very low priming volume of 95 to 110mLwhile
maintaining the standard safety features such as arterial line
filter. In some of the previous reports, hematocrit value dur-
ing CPB was allowed to decrease to 15%,4,16 whereas
hemoglobin concentration less than 7 g/dL, corresponding
to a hematocrit value of about 21%, was considered
a transfusion trigger in the present report. Hemodilution
to a hematocrit value of 15% seemed to be safe in
previous reports,4,16 but these concerned older children.
The possible hazards of hemodilution have to be weighed
against the expected benefits of transfusion-free surgical
procedures. It is still under debate what the safe hematocrit
level for neonates and infants under the conditions of CPB
and hypothermia may be.4 In anemic preterm infants with
hematocrit values less than 25%, blood transfusion in-
creased cerebral, splanchnic, and renal tissue oxygena-
tion.21,22 However, tissue oxygenation before transfusion
did not indicate tissue hypoxia and it is unclear whether
transfusions were well timed to avoid tissue hypoxia or
too early and possibly prooxidant.21 Several studies re-
ported lower psychomotor development in infants after
acute hemodilution during CPB to a hematocrit value less
than 22%23-25 during cardiac surgery. In a more recent
analysis, a linear correlation between psychomotor
development and hematocrit values between 15% and
23.5% during low-flow CPB was detected.26 That might
suggest that the transfusion trigger of hemoglobin less
than 7 g/dL in the present study could put some patients
at risk for cerebral injury. Indeed, 4 infants in our study
had a hematocrit value less than 23.5 % for a duration of
more than 5 minutes. However, conditions during CPB dif-
fer by higher temperature (26C-28C vs 18C) and higher
CPB flow (1.7-2.0 L $ min1 $ m2 vs 0.75 L $ min1 $ m2)
in our protocol. It is unknown how these differences would
actually affect cerebral tissue oxygenation and thus postop-
erative psychomotor development in our patients. In addi-
tion, cerebral oxygenation is continuously monitored in
our protocol, which we consider an additional safety mea-
sure that might help to avoid periods of cerebral hypoxia
during CPB.
Most of the previous reports include a mixed patient pop-
ulation with various congenital heart defects including
atrial or ventricular septal defects (50% of patients in the
report by Miyaji and associates18), which are characterized
by short CPB duration and aortic crossclamp time. Ando,
Takahashi, and Suzuki4 included only patients undergoing
ventricular septal defect repair, and CPB duration and aortic
crossclamp times were characteristically short (53 and 31
minutes, respectively). A longer CPB time has been shown
to be significantly associated with the need for blood trans-
fusion in infants.3,18 The present report includes only
neonates undergoing the arterial switch operation forery c October 2011
TABLE 3. Perioperative oxygenation and hemodynamic data
Group Preop Pre-CPB CPB start CPB mid CPB end Post-CPB Postop
Blood sample Art C-ven Art Art Art Art C-ven
PO2 (mm Hg) With blood 60  9 38  5 357  33* 270  15* 239  19* 102  37 31  2
W/o blood 53  6 34  2 336  21* 261  16* 244  18* 99  14* 29  1
SO2 (%) With 90.7  2.6 72.9  4.9 99.8  0.2* 99.7  0.1* 99.7  0.1* 94.3  1.8 62.7  3.2
W/o 89.9  2.0 71.9  3 6 99.6  0.1* 99.5  0.1* 99.  0.2* 97.4  0.6* 59.5  2.7*
C–O2 (mL/dL) With 14.8  1.5 11.5  1.7 10.1  0.7* 12.1  0.5* 14.5  0.7* 14.7  0.7 9.8  0.7
W/o 16.2  0.6 12.4  0.8 13.4  0.4*y 12.8  0.5* 12.9  0.5* 12.8  0.4* 7.8  0.5*
pH With 7.43  0.03 7.40  0.03 7.38  0.06 7.39  0.05 7.40  0.05 7.41  0.03 7.37  0.02
W/o 7.48  0.02 7.44  0.02 7.42  0.02 7.40  0.02 7.43  0.02 7.44  0.02 7.37  0.02
BE (mmol/L) With 0.5  0.8 0.5  0.5 4.41.0* 4.1  0.8* 3.9  0.7 3.2  0.8 2.4  0.7
W/o 0.5  0.8 1.2  0.7 2.0  0.6* 1.7  0.6* 0.2  0.6*y 0.6  0.7*y 0.6  0.8*
Lactate (mmol/L) With 1.4  0.3 1.8  0.3 2.0  0.4 3.6  0.5* 4.2  0.6* 4.0  0.6* 4.1  0.7*
W/o 1.3  0.1 1.4  0.1 1.5  0.2 2.3  0.2*y 2.4  0.3*y 2.4  0.2*y 2.4  0.2*y
Platelets (1000/mL) With 366  74 210  24
W/o 363  38 203  20*
Fibrinogen (mg/dL) With 191  35 149  23
W/o 265  23 127  9*
MAP (mm Hg) With 40  2 31  1 35  5 36  5 49  3 47  3 49  2
W/o 42  2 36  2 36  2 42  3 48  3 49  3 49  3
CVP (mm Hg) With 8.8  1.2 7.7  1.0 4.2  0.4* 4.2  2.2* 5.3  1.4* 7.3  1.2 6.7  0.8
W/o 7.7  0.5 6.1  0.5 4.5  0.8* 4.7  0.7* 5.5  0.6* 8.1  0.5 7.9  0.5
Temp (C) With 33.8  0.4 32.9  0. 29.9  1.8* 25.7  1.5* 35.4  0.9 35.5  0.3 35.3  0.2
W/o 34.4  0.2 33.0  0.6 31.4  0.5* 27.6  0.3* 34.4  0.6 35.7  0.2 35.7  0.2
CPB flow (mL $ min1 $ m2) With 2.5  0.4 1.7  0.4* 2.3  0.2
W/o 2.5  0.2 2.0  0.1* 2.6  0.2
CPB O2D (mL $ min
1 $ m2) With 256  48 194  37 326  29
W/o 340  25 255  18* 328  27
PO2/FIO2 (mm Hg) With 87  18 243  89*
W/o 94  9 247  33*
Art, Arterial blood sample; C-ven, central venous blood sample;W/o, without; Po2, oxygen tension; So2, oxygen saturation; C-O2, oxygen content; BE, base excess;MAP, mean
arterial pressure; CVP, central venous pressure; Temp, rectal temperature; CPB, cardiopulmonary bypass; O2D, oxygen delivery; Fio2, inspired gas mixture oxygen fraction. All
data are means  SEM. *P<.05 versus preop. yP<.05 versus neonates who received blood, both adjusted P values according to repeated-measures analysis of variance with
Holm-Sidak post hoc tests.
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procedure, CPB time was much longer (147 and 120
minutes in infants with and without blood, respectively),
with a trend for shorter time on CPB in the group without
blood (P ¼ .096). In a mixed patient population with
greater variability of CPB time, the association between
CPB duration and the need for blood may be more
pronounced.3,16,18 Among others, age, body weight, and
preoperative hematocrit value have been identified as
predictors for the need of blood transfusion.3,16,18 Within
the homogeneous patient population of the present study,
only preoperative hemoglobin concentration was
significantly lower in neonates who required blood
transfusion.
In the special population of this study, infants with the cy-
anotic cardiac defect TGA, arterial oxygen saturation in-
creased with the onset of CPB, which, together with lower
oxygen demand owing to hypothermia, more than compen-
sated for the effect of hemodilution on tissue oxygenation.
Thus, brain oxygenation increased in both groups duringThe Journal of Thoracic and CaCPB, indicating good maintenance of cerebral tissue oxy-
genation despite hemodilution. Lower body oxygenation
also increased in both groups, indicatingmaintenance of ox-
ygenation in peripheral tissues. Lactate concentration mod-
erately increased during CPB in both groups, yet it was
significantly more pronounced in the group with blood.
This increase can be partly attributed to application of lac-
tate with the transfused red blood cells in the group with
blood.
LIMITATION OF THE STUDY
The major limitation of this report is the small sample
size, which precludes definite conclusions about the safety
of the proposed protocol. Thus, the observation that no dif-
ferences among groups concerning in-hospital outcome
were detected, such as duration of ventilation and ICU
stay or incidence of postoperative complications, neither
proves that our protocol to avoid transfusion is safe nor dis-
proves the potential benefits by avoiding transfusion. In ad-
dition, the most relevant outcome measure, postoperativerdiovascular Surgery c Volume 142, Number 4 879
FIGURE 2. Cerebral tissue oxygenation (cerebral rSo2) as determined by
near-infrared spectroscopy during cardiac surgery is given for neonates
without intraoperative blood transfusion (w/o blood) and with blood trans-
fusion (with blood). Means  SEM; *P<.05 versus pre-Op. Differences
between groups were not significant. CPB, Cardiopulmonary bypass.
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Dmental and psychomotor development, was not assessed at
all. However, the goal of this study was to demonstrate how
a stringent blood-sparing approach including a very low
priming volume CPBwould affect intraoperative hemodilu-
tion and the need for transfusion of homologous blood prod-
ucts. Whether this approach has the potential to actually
improve outcome and what the safe hematocrit level for
this protocol might be have to be evaluated in future studies.
In conclusion, our results indicate that even complex car-
diac surgery can be performed in neonates without the need
for blood transfusion, at least in a subgroup of infants,FIGURE 3. Lower body tissue oxygenation (Lower Body rSO2) as deter-
mined by near-infrared spectroscopy on the infant’s calf during cardiac sur-
gery is given for neonates without intraoperative blood transfusion (w/o
blood) and with blood transfusion (with blood). Means  SEM; *P<.05
versus pre-Op. Differences between groups were not significant.CPB,Car-
diopulmonary bypass.
880 The Journal of Thoracic and Cardiovascular Surgwhereas cerebral and peripheral tissue oxygenation as as-
sessed by NIRS is maintained. Preliminary outcome data
suggest that despite lower postoperative hemoglobin con-
centration, the effort to avoid blood transfusion has no haz-
ardous consequences for the infants.References
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